Glaxosmithkline Plc (GSK) 45.39 -0.31

GlaxoSmithKline PLC ADS
(GSK) 45.39 -0.31

Last Trade:	44.75	Day Range:	44.49 - 44.82
Trade Time:	04:02PM	52wk Range:	36.39 - 46.40
Prev. Close:	45.06	Market Cap:	113.03B
Open:	44.49	Div Yield:	4.66
Volume:	2502156	PE:
EPS:	0.00

The Latest On GSK

Benzinga's M&A Chatter for Thursday February 9, 2012 2/9/12 5:58pm

Financial Breakfast: Morning News Summary for February 07, 2012 2/7/12 7:19am

Anacor Pharmaceuticals Down 14.4% After GlaxoSmithKline Pauses Ongoing Trials 2/6/12 9:20am

Verastem IPO Launch Captures Investors Attention 2/1/12 10:54pm

Benzinga's M&A Chatter for Tuesday January 31, 2012 1/31/12 7:13pm

Benzinga's M&A Chatter for Wednesday January 25, 2012 1/25/12 8:04pm

Taking a Closer Look at Investing in Singapore 1/17/12 1:52pm

Fast Money Picks For January 13th (JPM, RBS, CHS, GSK, BBBY, CCL) 1/12/12 7:42pm

Notable Put Options Activity in GlaxoSmithKline 1/9/12 12:15pm

From Earlier: GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair in COPD and Asthma 1/9/12 7:16am

Benzinga's M&A Chatter for Friday January 6, 2012 1/6/12 4:51pm

ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 1/5/12 8:07am

Benzinga's M&A Chatter for Thursday February 9, 2012 2/9/12

Financial Breakfast: Morning News Summary for February 07, 2012 2/7/12

Anacor Pharmaceuticals Down 14.4% After GlaxoSmithKline Pauses Ongoing Trials 2/6/12

Verastem IPO Launch Captures Investors Attention 2/1/12

Benzinga's M&A Chatter for Tuesday January 31, 2012 1/31/12

Benzinga's M&A Chatter for Wednesday January 25, 2012 1/25/12

Taking a Closer Look at Investing in Singapore 1/17/12

Fast Money Picks For January 13th (JPM, RBS, CHS, GSK, BBBY, CCL) 1/12/12

Notable Put Options Activity in GlaxoSmithKline 1/9/12

From Earlier: GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair in COPD and Asthma 1/9/12

Benzinga's M&A Chatter for Friday January 6, 2012 1/6/12

ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 1/5/12

Benzinga's M&A Chatter for Thursday February 9, 2012 2/9/12

Financial Breakfast: Morning News Summary for February 07, 2012 2/7/12

Verastem IPO Launch Captures Investors Attention 2/1/12

Benzinga's M&A Chatter for Tuesday January 31, 2012 1/31/12

Benzinga's M&A Chatter for Wednesday January 25, 2012 1/25/12

Taking a Closer Look at Investing in Singapore 1/17/12

Fast Money Picks For January 13th (JPM, RBS, CHS, GSK, BBBY, CCL) 1/12/12

Benzinga's M&A Chatter for Friday January 6, 2012 1/6/12

Fast Money Picks For December 20th (SVU, CLWR, AA, GSK, TLT, V) 12/19/11

Pfizer Earnings Preview: Analysts Expect Higher EPS, Revenue 10/27/11

Allergan Earnings Preview: Analysts Expect Higher EPS, Revenue 10/25/11

Earnings Preview: Vertex Pharmaceuticals' EPS, Revenue Expected to Rise 10/25/11

Financial Breakfast: Morning News Summary for February 07, 2012 2/7/12

Citigroup Initiates GlaxoSmithKline at Buy 11/29/11

Piper Jaffray Believes Timing is Right for GSK to Buy Human Genome Sciences 10/18/11

Citi Comments On GSK 7/25/11

Piper Jaffray Comments On XenoPort Following FDA Approval 4/7/11

Benzinga's Top Upgrades (TRN, ANF, CAM, GSK) 2/14/11

Exane BNP Paribas Ups GSK To Outperform 2/14/11

Piper Jaffray Defends THRX Following Delayed Sell-Off 1/31/11

Morgan Stanley Downgrades GlaxoSmithKline to Underweight (GSK) 1/19/11

Jefferies Upgrades GSK To Buy, Anticipates Positive Earnings Momentum 1/11/11

Jefferies Upgrades GlaxoSmithKline (GSK) 1/11/11

Benzinga's Top Upgrades (HPQ, FLR, GSK, M) 1/11/11

Trade GSK
NOW!

Partner Headlines

GlaxoSmithKline Close to Important Technical Levels 2/10/12

Speedy Review for Roche Drug - Analyst Blog 2/9/12

GlaxoSmithKline in a Well Defined Range 2/9/12

Ten Big Pharma Stocks' Juicy Dividend Payouts, With Cash-on-Hand as Cushion 2/8/12

Amgen Upped to Outperform - Analyst Blog 2/8/12

Glaxo Misses Estimates by a Mile - Analyst Blog 2/8/12

Glaxo swings to profit in Q4 2/7/12

GlaxoSmithKline Swings To Profit But Shy Of Estimates 2/7/12

Stocks to Watch: BP, Coca-Cola 2/7/12

Stocks to Watch: Coca-Cola, BP (Update 1) 2/7/12

Incivek Catalyst at Play for Vertex - Analyst Blog 2/3/12

The Best Yielding Healthcare Dividend Stocks with Fastest Earnings Growth 2/2/12

Press Releases

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results 2/9/12 Business Wire Story

Prestige Brands Holdings, Inc. Reports Fiscal 2012 Third Quarter Sales Increase of 17.3%; Operating Income Up 81.4%; Acquisition of 15 OTC Brands from GSK Completed 2/9/12 Business Wire Story

Amgen to Discuss Application for New Use of XGEVA® (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting 2/8/12 Newswire Story

Medivir: Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe under Trade Names Zoviduo and Zovirax Duo 2/8/12 Business Wire Story

Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe Under Trade Names Zoviduo and Zovirax Duo 2/8/12 Newswire Story

Arzerra Fourth Quarter and Full Year 2011 Net Sales Figures 2/7/12 GlobeNewswire Story

C3 Jian Appoints Vice President, Production and Facilities 2/6/12 GlobeNewswire Story

Anacor Pharmaceuticals Announces That Its Partner GSK Has Voluntarily Paused Enrollment of Ongoing GSK '052 Phase 1 and 2 Clinical Trials 2/6/12 Business Wire Story

Prestige Brands Holdings, Inc. Completes Purchase of 15 Brands from GSK 1/31/12 Business Wire Story

TapImmune Chairman and CEO Provides Corporate Update to Current and Future Shareholders 1/30/12 GlobeNewswire Story

London 2012 Unveils Anti-Doping Laboratory 1/21/12 PRWeb Story

La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist 1/20/12 Business Wire Story

Get the latest GSK stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for GlaxoSmithKline PLC ADS stock price.

GlaxoSmithKline PLC ADS by YCharts

Glaxosmithkline Plc (GSK) 45.39 -0.31

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On GSK

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social